Independently tested. Verified pure. Made for research.
Ordino supplies synthetic peptides to biotech and pharmaceutical R&D teams. Every lot ships with independent RP-HPLC, LC-MS identity and endotoxin data. A summary of the published literature on each compound is available here on the Ordino Research site.
Featured monographs
All 5 compounds →Tirzepatide
Incretin & metabolicA 39-amino-acid synthetic peptide engineered as a dual agonist of the GIP and GLP-1 receptors.
Retatrutide
Incretin & metabolicLY3437943: a single peptide with agonist activity at the GIP, GLP-1 and glucagon receptors.
BPC-157
Tissue repairBody Protection Compound-157 is a synthetic pentadecapeptide based on part of a protein found in human gastric juice.
GHK-Cu
Copper & dermalGlycyl-L-histidyl-L-lysine is a naturally occurring tripeptide, first isolated from human plasma, that binds copper(II) with high affinity.
Browse by class
Compounds grouped by receptor family or research area. Each links to a filtered catalog.
Release criteria are published, not implied.
Quality & testing →Fmoc solid-phase synthesis, with preparative HPLC purification to target.
LC-MS confirms observed mass within ±1.0 Da of theoretical.
RP-HPLC at 220 nm, ≥98.0% by area. Tested by a third-party lab, not in-house.
LAL endotoxin, Karl Fischer water and peptide content, then lot release.